Finance

Lists
Q3 2026 earnings • in 3 days
See details
ANIK:NASDAQ
Anika Therapeutics Inc
$19.36
-0.26%
(-0.050) 1D
Nov 3, 11:01:18 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIK...
Open
$19.53
High
$21.55
Low
$19.08
Mkt. cap
259.09M
Avg. vol.
102.73K
Volume
24.05K
52-wk high
$22.88
52-wk low
$9.01
EPS
-$0.27
Beta
0.21
Shares outstanding
13.38M
No. of employees
235
Open
$19.53
High
$21.55
Low
$19.08
Mkt. cap
259.09M
Avg. vol.
102.73K
Volume
24.05K
52-wk high
$22.88
52-wk low
$9.01
EPS
-$0.27
Beta
0.21
Shares outstanding
13.38M
No. of employees
235
News stories
From web sources and news partners
About Anika Therapeutics Inc
CEO-
Employees235
Founded1983
HeadquartersBedford, Massachusetts, United States
SectorBiotechnology
Websiteanika.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANIK in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANIK in the last 3 months.
Highest
Current $19.36
$23.00 (+18.80%)
Average
$23.00 (+18.80%)
Lowest
$23.00 (+18.80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
$23.00
+18.8%
10/22/2026
Madison Elsaadi
B. Riley Securities
Buy
Initiated
$23.00
+18.8%
09/18/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
$21.00
+8.5%
07/30/2026
Next call in 3 days
Fri, Nov 6, 8:30 AM
Fiscal period
Q3 2026
- / $0.17
Revenue / Est. (USD)
- / 29.44M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
27.82M
30.62M
29.61M
32.61M
Cost of goods sold
12.23M
11.44M
10.62M
11.37M
Cost of revenue
12.23M
11.44M
10.62M
11.37M
Research and development expenses
6.95M
6.45M
6.71M
7.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.87M
12.08M
16.18M
10.18M
Operating expense
18.82M
18.53M
22.90M
17.52M
Total operating expenses
31.05M
29.97M
33.51M
28.88M
Operating income
-3.23M
646.00K
-3.90M
3.73M
Other non operating income
-
-
-
-
EBT including unusual items
-2.24M
764.00K
-4.82M
3.38M
EBT excluding unusual items
-2.24M
764.00K
-3.23M
4.15M
Income tax expense
939.00K
-1.04M
235.00K
71.00K
Effective tax rate
-41.99%
-135.73%
-4.87%
2.10%
Other operating expenses
-
-
-
-
Net income
-2.33M
292.00K
-5.06M
3.31M
Net profit margin
-8.37%
0.95%
-17.07%
10.15%
Earnings per share
0.04
0.31
0.27
0.42
Interest and investment income
997.00K
118.00K
667.00K
426.00K
Interest expense
-
-
-
-
Net interest expenses
997.00K
118.00K
667.00K
426.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.83M
1.96M
-2.49M
5.23M
Gain or loss from assets sale
-451.00K
790.00K
-52.00K
-32.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps